J84.89

cryptogenic organizing pneumonia (J84.116) idiopathic non-specific interstitial pneumonitis (J84.113) lipoid pneumonia, exogenous or unspecified (J69.1) lymphoid interstitial pneumonia (J84.2)

code, for adverse effect, to identify drug (T36-T50 with fifth or sixth character 5), if drug-induced

, if applicable: poisoning due to drug or toxin (T51-T65 with fifth or sixth character to indicate intent), for toxic pneumonopathy underlying cause of pneumonopathy, if known

Endogenous lipoid pneumonia Interstitial pneumonitis Non-specific interstitial pneumonitis NOS Organizing pneumonia NOS

exogenous lipoid pneumonia (J69.1) unspecified lipoid pneumonia (J69.1)

drug-induced interstitial lung disorders (J70.2-J70.4) interstitial emphysema (J98.2)

lung diseases due to external agents (J60-J70)

, if applicable, associated condition

certain conditions originating in the perinatal period (P04-P96) certain infectious and parasitic diseases (A00-B99) complications of pregnancy, childbirth and the puerperium (O00-O9A) congenital malformations, deformations and chromosomal abnormalities (Q00-Q99) endocrine, nutritional and metabolic diseases (E00-E88) injury, poisoning and certain other consequences of external causes (S00-T88) neoplasms (C00-D49) smoke inhalation (T59.81-) symptoms, signs and abnormal clinical and laboratory findings, not elsewhere classified (R00-R94)

code, where applicable, to identify: exposure to environmental tobacco smoke (Z77.22) exposure to tobacco smoke in the perinatal period (P96.81) history of tobacco dependence (Z87.891) occupational exposure to environmental tobacco smoke (Z57.31) tobacco dependence (F17.-) tobacco use (Z72.0)

When a respiratory condition is described as occurring in more than one site and is not specifically indexed, it should be classified to the lower anatomic site (e.g. tracheobronchitis to bronchitis in J40).